Red Meat and Colorectal Cancer

por Aykan, Nuri Faruk
Publicado 2015

Objective response rate assessment in oncology: Current situation and future expectations

por Aykan, Nuri Faruk, Özatlı, Tahsin
Publicado 2020

Imatinib response of gastrointestinal stromal tumor patients with germline mutation on KIT exon 13: A family report

por Engin, Gulgun, Eraslan, Serpil, Kayserili, Hülya, Kapran, Yersu, Akman, Haluk, Akyuz, Ali, Aykan, Nuri Faruk
Publicado 2017

Clinical significance of serum claudin-1 and claudin-7 levels in patients with colorectal cancer

por KARABULUT, MEHMET, ALIS, HALIL, BAS, KORAY, KARABULUT, SENEM, AFSAR, CIGDEM USUL, OGUZ, HILAL, GUNALDI, MERAL, AKARSU, CEVHER, KONES, OSMAN, AYKAN, NURI FARUK
Publicado 2015

Evaluation of epidermal growth factor receptor serum levels and their association with clinicopathological characteristics in patients with colorectal cancer

por Karabulut, Mehmet, Afsar, Cigdem Usul, Alıs, Halil, Oran, Ebru, Karabulut, Senem, Akarsu, Cevher, Sahbaz, Nuri Alper, Gümüsoglu, Alpen Yahya, Bilgin, Elif, Aykan, Nuri Faruk
Publicado 2017

Safety and efficacy of regorafenib in patients with treatment-refractory metastatic colorectal cancer in Turkey: the single-arm, open-label REGARD study

por Dane, Faysal, Ozgurdal, Kirhan, Yalçın, Şuayib, Benekli, Mustafa, Aykan, Nuri Faruk, Yücel, İdris, Özkan, Metin, Evrensel, Turkkan, Sevinç, Alper, Coskun, Hasan Şenol, Sanli, Ulus Ali, Kara, Ismail Oguz, Yumuk, Perran Fulden
Publicado 2020